Red blood cell transfusion in autoimmune hemolytic anemia

Orin W. Buetens, Paul M. Ness

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations


Purpose of review: Transfusion, in the setting of autoimmune hemolytic anemia, can be a complicated and potentially dangerous proposition. Recent findings: The selection and delivery of an appropriate red blood cell unit must focus on several areas: (1) the laboratory detection of the autoantibody, (2) the detection of clinically significant red blood cell alloantibodies potentially masked by the autoantibodies, and (3) the selection and delivery of appropriate, although potentially incompatible, units. In addition, alternatives to red blood cell transfusion, specifically red blood cell substitutes, may also play an important role in the clinical treatment of these patients in the future. Summary: In this article, we will review the most recent developments in the transfusion management of patients with autoimmune hemolytic anemia, specifically focusing on published articles between the period of May 2002 to April 2003.

Original languageEnglish (US)
Pages (from-to)429-433
Number of pages5
JournalCurrent opinion in hematology
Issue number6
StatePublished - Nov 1 2003


  • Autoantibodies
  • Autoimmune hemolytic anemia
  • Red blood cell substitutes
  • Transfusion

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Red blood cell transfusion in autoimmune hemolytic anemia'. Together they form a unique fingerprint.

Cite this